These are our stories, our realities

Exciting breakthrough in antibody research

Leveraging 400 million years of evolution, Lundbeck and biotech company Ossianix has reached an important milestone in our work to use shark antibodies to enable delivery of therapeutic drugs into the brain.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.